Oaktree Acquisition Holdings III LS, LLC bought OACC

October 23, 2026 · Form 4 insider transaction

Oaktree Acquisition Holdings III LS, LLC bought 4,798,758 shares of Oaktree Acquisition Corp. III Life Sciences, a transaction worth N/A. The trade was recorded as conversion of a derivative and disclosed on an SEC Form 4, filed 0 days after the transaction.

Direction
Acquired (buy-side)
Shares
4,798,758
Price
N/A
Total value
N/A
Role10% owner
SecurityClass A Ordinary Shares
Transaction codeC: Conversion of a derivative
Transaction dateOctober 23, 2026
Filing dateOctober 23, 2026
Shares owned after5,382,739
OwnershipDirect
10b5-1 planNo
AmendedNo

Footnotes

Class B ordinary shares are automatically convertible into Class A ordinary shares at the time of the Issuer's initial business combination on a one-for-one basis or earlier at the option of the holder.; The reported securities are directly held by Oaktree Acquisition Holdings III LS, LLC ("Holdings"). The managing member of Holdings is Oaktree Acquisition Holdings III LS GP, Ltd. ("Holdings GP"). The director of Holdings GP is Oaktree Capital Management, L.P. ("OCM"). The general partner of OCM is Oaktree Capital Management GP, LLC ("OCM GP"). The sole managing member of OCM GP is Oaktree Capital Holdings, LLC. Each of the Reporting Persons disclaims beneficial ownership of the reported securities except to the extent of their respective pecuniary interest therein and the filing of this Statement shall not be construed as an admission that any such Reporting Person is the beneficial owner of the reported securities covered by this Statement.

View the original Form 4 on SEC EDGAR